LYTIR

Company · INM

InMed Pharmaceuticals Inc.

INM is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 19, 2026: insiders bought on 23 occasions ($282K); 7 filings by holders of 5% or more; 6 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 55, No. 54, No. 53, No. 52, No. 51, No. 50

Insider purchases and sales, by month (last 12 months)Insider purchases: $282K in total; Insider sales: $0 in total.Jun: Insider purchases $924Jul: Insider purchases $43KSep: Insider purchases $118KOct: Insider purchases $86KNov: Insider purchases $35KDecJanFebMarAprMayJunJulAugSepOctNov$118K
Insider purchases above the line: $282KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. ADAR1 Capital Management, LLC bought on 17 days latest Nov 5, 2026 bought $240K
  2. Vivo Opportunity, LLC bought on 6 days latest Jul 16, 2026 bought $42K
Every trade (23)
  1. BUYADAR1 Capital Management, LLC bought Nov 5, 2026 2,640 shares filing $35K
  2. BUYADAR1 Capital Management, LLC bought Oct 23, 2026 4 shares filing $5
  3. BUYADAR1 Capital Management, LLC bought Oct 19, 2026 1,086 shares filing $1K
  4. BUYADAR1 Capital Management, LLC bought Oct 16, 2026 1 shares filing $1
  5. BUYADAR1 Capital Management, LLC bought Oct 15, 2026 984 shares filing $1K
  6. BUYADAR1 Capital Management, LLC bought Oct 14, 2026 8,021 shares filing $11K
  7. BUYADAR1 Capital Management, LLC bought Oct 13, 2026 564 shares filing $750
  8. BUYADAR1 Capital Management, LLC bought Oct 8, 2026 2,256 shares filing $3K
  9. BUYADAR1 Capital Management, LLC bought Oct 7, 2026 3,046 shares filing $4K
  10. BUYADAR1 Capital Management, LLC bought Oct 6, 2026 5,601 shares filing $7K
  11. BUYADAR1 Capital Management, LLC bought Oct 5, 2026 18,182 shares filing $24K
  12. BUYADAR1 Capital Management, LLC bought Oct 2, 2026 8,307 shares filing $11K
  13. BUYADAR1 Capital Management, LLC bought Oct 1, 2026 16,431 shares filing $22K
  14. BUYADAR1 Capital Management, LLC bought Sep 16, 2026 8,340 shares filing $11K
  15. BUYADAR1 Capital Management, LLC bought Sep 15, 2026 54,256 shares filing $70K
  16. BUYADAR1 Capital Management, LLC bought Sep 14, 2026 28,505 shares filing $37K
  17. BUYVivo Opportunity, LLC bought Jul 16, 2026 21 shares 2 legs combined filing $33
  18. BUYVivo Opportunity, LLC bought Jul 15, 2026 15,150 shares 2 legs combined filing $23K
  19. BUYADAR1 Capital Management, LLC bought Jul 15, 2026 1,000 shares filing $2K
  20. BUYVivo Opportunity, LLC bought Jul 14, 2026 5,375 shares 2 legs combined filing $8K
  21. BUYVivo Opportunity, LLC bought Jul 2, 2026 1,607 shares 2 legs combined filing $2K
  22. BUYVivo Opportunity, LLC bought Jul 1, 2026 4,344 shares 2 legs combined filing $7K
  23. BUYVivo Opportunity, LLC bought Jun 30, 2026 600 shares 2 legs combined filing $924

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Squadron Master Fund LP filed Nov 16, 2026 Schedule 13G/A passive filing 0%
  2. Deep Track Capital, LP filed Nov 13, 2026 Schedule 13G passive 2,977,478 shares issuer: Mentari Therapeutics, Inc. filing 5.64%
  3. Commodore Capital LP filed Nov 13, 2026 Schedule 13G passive issuer: Mentari Therapeutics, Inc. filing 5.6%
  4. Fairmount Funds Management LLC filed Nov 12, 2026 Schedule 13D may seek influence 10,555,507 shares issuer: Mentari Therapeutics, Inc. filing 19.99%
  5. ADAR1 Capital Management, LLC filed Oct 7, 2026 Schedule 13G/A passive filing 17.2%
  6. Ikarian Capital, LLC filed Aug 14, 2026 Schedule 13G passive filing 4.2%
  7. Vivo Opportunity Fund Holdings, L.P. filed Jun 10, 2026 Schedule 13D may seek influence 718,444 shares filing 21.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Results of operations and financial condition; Unregistered sales of equity securities; Material modification to rights of security holders; Change in control; Departure or appointment of directors or officers; Amendments to articles or bylaws; change in fiscal year; Amendments to or waiver of the code of ethics; Change in shell company status filing Nov 10, 2026
  2. Regulation FD disclosure filing Nov 9, 2026
  3. Amendments to articles or bylaws; change in fiscal year; Submission of matters to a vote of security holders; Other events filing Nov 5, 2026
  4. Regulation FD disclosure filing Nov 5, 2026
  5. Regulation FD disclosure filing Nov 3, 2026
  6. Notice of delisting or failure to meet a listing standard; Other events filing Sep 18, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.